The chemical classification of C9orf105 Activators would be a group of molecular entities specifically designed to interact with and enhance the activity of the protein product of the C9orf105 gene. The designation C9orf105 indicates that this is a gene located on chromosome 9, within an open reading frame, denoted by orf, which suggests that it has been identified as a sequence in the human genome that could potentially code for a protein. As of the last update, it is conceivable that C9orf105 may not be well characterized, which means that comprehensive data on the protein's structure, function, and biological significance might be limited. Assuming C9orf105 encodes a protein, activators for this protein would be specialized compounds that increase its biological activity. This activity could be manifested in various ways, such as through the enhancement of protein expression, assistance in appropriate protein folding, stabilization of the protein structure to prevent degradation, or by facilitating interactions with other cellular molecules. The initial steps in the development of C9orf105 activators would likely center on a deep understanding of the protein's three-dimensional structure and its role within cellular processes, which would necessitate sophisticated analytical techniques including protein expression profiling, molecular docking studies, and high-throughput screening assays to identify promising activator candidates.
In the subsequent research phase, the focus would shift to exhaustive characterization of the identified C9orf105 activators. Scientists would delve into the study of how these molecules interact with the C9orf105 protein, analyzing the mechanisms by which they enhance the protein's activity. This would involve a range of biophysical and biochemical experiments, such as binding assays to measure the affinity of the activators to the C9orf105 protein, and kinetic studies to elucidate the changes in reaction rates induced by the activators. Structural studies, possibly employing techniques like X-ray crystallography or cryo-electron microscopy, might be undertaken to visualize the activator-protein complex at an atomic level, thereby revealing the specific binding sites and conformational shifts associated with activation. Additionally, iterative chemical synthesis would be employed to optimize the efficacy and selectivity of these activator molecules, with the aim of enhancing their interaction with the C9orf105 protein. Through these diverse and complex research methodologies, scientists would be able to gain a more intricate understanding of the C9orf105 protein's functionality and the cellular pathways it influences, with activators serving as crucial tools for probing and elucidating its biological significance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression through its role as an activator of retinoic acid receptors, which may influence C9orf105 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a component of green tea, is known to modulate gene expression and could potentially affect C9orf105. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to modulate various signaling pathways and could hypothetically influence C9orf105 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone from soy, acts as a tyrosine kinase inhibitor and modulates gene expression, possibly affecting C9orf105. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate can lead to a more relaxed chromatin state and potentially influence C9orf105 expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, impacting nucleotide synthesis and potentially gene expression, including C9orf105. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 and its active form can modulate gene expression through the vitamin D receptor, potentially influencing C9orf105 expression. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Cadmium is a heavy metal that can induce various stress responses and may affect gene expression, including that of C9orf105. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide can lead to oxidative stress and affect signal transduction pathways, potentially influencing gene expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation and can trigger the unfolded protein response, which may influence gene expression patterns. | ||||||